Rifater Articles
Rifater Marketed In USA
14 November 1994
Mixed Results From US Companies In 2nd Qtr
8 August 1994
MMD RECEIVES FDA OK FOR RIFATER
13 June 1994
US NDA FILED FOR RIFATER
12 July 1993
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
